Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

UGT1A8 Activators

UGT1A8 activators can be conceptualized as a group of chemical entities specifically designed or identified to augment or stimulate the activity of the UGT1A8 enzyme, part of the broader UDP-glucuronosyltransferase (UGT) family. The primary function of UGT enzymes is the glucuronidation of various endogenous and exogenous substances, which facilitates their detoxification and subsequent excretion from the body. Given the importance of this metabolic pathway, particularly in the intestines where UGT1A8 predominantly expresses, compounds that can enhance its activity have garnered interest from a biochemical standpoint. Direct activators in this class might interact with UGT1A8 by binding to specific regions on the enzyme, either promoting its glucuronidation activity or safeguarding it from inhibitors. On a molecular level, the interaction could bring about structural alterations to the protein, optimizing its substrate affinity or its catalytic efficiency.

In contrast, indirect activators might not engage UGT1A8 on a molecular level. Instead, their modus operandi involves influencing cellular or biochemical pathways that, in turn, bolster UGT1A8's expression or function. For instance, an indirect activator might stimulate transcription factors that heighten the transcription of the UGT1A8 gene, leading to higher protein synthesis and subsequent enhanced glucuronidation capability. Another plausible mechanism is the suppression of cellular components that might repress UGT1A8's expression or activity, thus creating an environment where the enzyme can function without impediments. Exploring the realm of UGT1A8 activators necessitates a deep understanding of the enzyme's biochemistry and its intricate cellular and systemic interactions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin can induce the expression of various UGT enzymes by activating nuclear receptors.

Oltipraz

64224-21-1sc-205777
sc-205777A
500 mg
1 g
$286.00
$622.00
(1)

Oltipraz may upregulate phase II detoxifying enzymes, potentially inducing UGT1A8 expression.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

As a glucocorticoid, dexamethasone can modulate the expression of several metabolic enzymes, possibly influencing UGT1A8.

Chrysin

480-40-0sc-204686
1 g
$38.00
13
(1)

Chrysin has been studied for its potential to induce certain UGT enzymes, which may include UGT1A8.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane has potential in inducing phase II detoxification enzymes, which may impact UGT1A8 expression.

Indole-3-carbinol

700-06-1sc-202662
sc-202662A
sc-202662B
sc-202662C
sc-202662D
1 g
5 g
100 g
250 g
1 kg
$39.00
$61.00
$146.00
$312.00
$1032.00
5
(1)

This compound, found in cruciferous vegetables, can modulate phase I and II enzymes, possibly affecting UGT1A8.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol may influence the expression of detoxifying enzymes, which could include UGT1A8.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin has potential in modulating the activity and expression of drug-metabolizing enzymes, potentially affecting UGT1A8.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin has been studied for its ability to modulate various UGT enzymes, which may encompass UGT1A8.